FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055603146> ?p ?o ?g. }

• W2055603146 endingPage "335" @default.
• W2055603146 startingPage "327" @default.
• W2055603146 abstract "Abstract BACKGROUND: Imatinib is an effective tyrosine kinase inhibitor (TKI) for patients with chronic myeloid leukemia (CML) in chronic phase (CP). Although some patients may fail on therapy with imatinib, effective salvage therapy is available with second‐generation TKIs. Current measurement of efficacy for each therapy is judged by its individual impact on overall survival and event‐free survival (EFS). METHODS: In total, 586 patients with CML in CP who received imatinib were included in this analysis in 2 cohorts: imatinib as front‐line therapy (n = 281) or after failure on interferon‐α (IFN‐α) (n = 305). By accounting for successful salvage treatment (ie, regain of complete cytogenetic response), the current EFS (CEFS) rate was calculated to obtain a more accurate impression of the outcome of patients with CML who received treatment with sequential TKIs. RESULTS: For patients who received imatinib after failing on IFN‐α, the 7‐year EFS rate was 61%, whereas the CEFS rate was 69%. The 7‐year EFS rate for patients who received imatinib as initial therapy was 81% compared with a 7‐year CEFS rate of 88%. CONCLUSIONS: CEFS provided a more accurate representation of the outcome of patients with CML in CP. These patients may frequently be treated successfully with subsequent TKIs after experiencing failure on the first TKI. Cancer 2011. © 2010 American Cancer Society" @default.
• W2055603146 created "2016-06-24" @default.
• W2055603146 creator A5006104041 @default.
• W2055603146 creator A5008422091 @default.
• W2055603146 creator A5015140142 @default.
• W2055603146 creator A5019337932 @default.
• W2055603146 creator A5027845051 @default.
• W2055603146 creator A5049385583 @default.
• W2055603146 creator A5055045706 @default.
• W2055603146 creator A5059555096 @default.
• W2055603146 creator A5085521139 @default.
• W2055603146 creator A5090435894 @default.
• W2055603146 date "2010-09-15" @default.
• W2055603146 modified "2023-10-18" @default.
• W2055603146 title "Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia" @default.
• W2055603146 cites W1602584478 @default.
• W2055603146 cites W1964358866 @default.
• W2055603146 cites W1983852790 @default.
• W2055603146 cites W1986635169 @default.
• W2055603146 cites W1990020715 @default.
• W2055603146 cites W2009746825 @default.
• W2055603146 cites W2016960626 @default.
• W2055603146 cites W2046269728 @default.
• W2055603146 cites W2054251966 @default.
• W2055603146 cites W2057718276 @default.
• W2055603146 cites W2068977368 @default.
• W2055603146 cites W2070067474 @default.
• W2055603146 cites W2080125373 @default.
• W2055603146 cites W2107268345 @default.
• W2055603146 cites W2108472756 @default.
• W2055603146 cites W2116153687 @default.
• W2055603146 cites W2120033838 @default.
• W2055603146 cites W2128738046 @default.
• W2055603146 cites W2135620625 @default.
• W2055603146 cites W2151968496 @default.
• W2055603146 cites W2157436488 @default.
• W2055603146 cites W2158884958 @default.
• W2055603146 cites W2172189430 @default.
• W2055603146 cites W2314938037 @default.
• W2055603146 cites W2337277825 @default.
• W2055603146 doi "https://doi.org/10.1002/cncr.25604" @default.
• W2055603146 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4327987" @default.
• W2055603146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20845478" @default.
• W2055603146 hasPublicationYear "2010" @default.
• W2055603146 type Work @default.
• W2055603146 sameAs 2055603146 @default.
• W2055603146 citedByCount "19" @default.
• W2055603146 countsByYear W20556031462012 @default.
• W2055603146 countsByYear W20556031462013 @default.
• W2055603146 countsByYear W20556031462014 @default.
• W2055603146 countsByYear W20556031462015 @default.
• W2055603146 countsByYear W20556031462016 @default.
• W2055603146 countsByYear W20556031462017 @default.
• W2055603146 countsByYear W20556031462019 @default.
• W2055603146 crossrefType "journal-article" @default.
• W2055603146 hasAuthorship W2055603146A5006104041 @default.
• W2055603146 hasAuthorship W2055603146A5008422091 @default.
• W2055603146 hasAuthorship W2055603146A5015140142 @default.
• W2055603146 hasAuthorship W2055603146A5019337932 @default.
• W2055603146 hasAuthorship W2055603146A5027845051 @default.
• W2055603146 hasAuthorship W2055603146A5049385583 @default.
• W2055603146 hasAuthorship W2055603146A5055045706 @default.
• W2055603146 hasAuthorship W2055603146A5059555096 @default.
• W2055603146 hasAuthorship W2055603146A5085521139 @default.
• W2055603146 hasAuthorship W2055603146A5090435894 @default.
• W2055603146 hasBestOaLocation W20556031461 @default.
• W2055603146 hasConcept C121608353 @default.
• W2055603146 hasConcept C126322002 @default.
• W2055603146 hasConcept C143998085 @default.
• W2055603146 hasConcept C170493617 @default.
• W2055603146 hasConcept C2776283816 @default.
• W2055603146 hasConcept C2777583451 @default.
• W2055603146 hasConcept C2778729363 @default.
• W2055603146 hasConcept C2778820342 @default.
• W2055603146 hasConcept C3019892230 @default.
• W2055603146 hasConcept C42362537 @default.
• W2055603146 hasConcept C71924100 @default.
• W2055603146 hasConceptScore W2055603146C121608353 @default.
• W2055603146 hasConceptScore W2055603146C126322002 @default.
• W2055603146 hasConceptScore W2055603146C143998085 @default.
• W2055603146 hasConceptScore W2055603146C170493617 @default.
• W2055603146 hasConceptScore W2055603146C2776283816 @default.
• W2055603146 hasConceptScore W2055603146C2777583451 @default.
• W2055603146 hasConceptScore W2055603146C2778729363 @default.
• W2055603146 hasConceptScore W2055603146C2778820342 @default.
• W2055603146 hasConceptScore W2055603146C3019892230 @default.
• W2055603146 hasConceptScore W2055603146C42362537 @default.
• W2055603146 hasConceptScore W2055603146C71924100 @default.
• W2055603146 hasIssue "2" @default.
• W2055603146 hasLocation W20556031461 @default.
• W2055603146 hasLocation W20556031462 @default.
• W2055603146 hasLocation W20556031463 @default.
• W2055603146 hasLocation W20556031464 @default.
• W2055603146 hasOpenAccess W2055603146 @default.
• W2055603146 hasPrimaryLocation W20556031461 @default.
• W2055603146 hasRelatedWork W2002247001 @default.
• W2055603146 hasRelatedWork W2034964376 @default.
• W2055603146 hasRelatedWork W2070391470 @default.

• next